Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation
NCT01386775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2012-06-28
Summary
This study in affected Hypohidrotic Ectodermal Dysplasia (HED) males and unaffected male controls, age 1 year and up, will use minimally invasive devices to image sweat ducts in intact skin, to measure stimulated sweat rate, and in a subset of subjects to collect clipped scalp hair samples for RNA analysis. This study is descriptive in nature and is intended to assess the ability to use innovative approaches to generate data from subjects over a wide age spectrum, with particular emphasis on phenotype variability between male siblings (same mutation).
Conditions
- Hypohidrotic Ectodermal Dysplasia
Sponsors & Collaborators
-
Edimer Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Dorothy K Grange, MD · Washington University School of Medicine
Eligibility
- Min Age
- 1 Year
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2011-07-31
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status
NCT01629940 ·Status: COMPLETED
-
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia
NCT02099552 ·Status: COMPLETED
-
A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED
NCT03912792 ·Status: WITHDRAWN
-
Sweat Duct Imaging in Mother/Newborn Dyads
NCT01342133 ·Status: COMPLETED
-
Phenotypic Properties in Individuals Affected With XLHED
NCT01871714 ·Status: COMPLETED
-
A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200
NCT01564225 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002
NCT01992289 ·Status: UNKNOWN
-
Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
NCT01775462 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia
NCT01308333 ·Status: COMPLETED
-
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey
NCT01398813 ·Status: COMPLETED
-
Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study
NCT07096206 ·Status: ACTIVE_NOT_RECRUITING
-
MCT8 Deficiency Caregiver Study
NCT06060197 ·Status: COMPLETED
-
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
NCT04980638 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Dysregulation of Core Body Temperature on Sleep in Patients With Hypohidrotic Ectodermal Dysplasia
NCT05378932 ·Status: COMPLETED ·Phase: NA
-
Study of Skeletal Disorders
NCT05031507 ·Status: RECRUITING
-
Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
NCT00303368 ·Status: COMPLETED
-
Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia
NCT01135888 ·Status: COMPLETED
-
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency
NCT05911399 ·Status: AVAILABLE
-
Evaluating Precision of Therapy - Milrinone
NCT01841177 ·Status: COMPLETED ·Phase: PHASE2
-
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556 ·Status: COMPLETED
-
A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
NCT05408715 ·Status: RECRUITING
-
Cardiac Outcome Measures in Children With Muscular Dystrophy
NCT01066455 ·Status: COMPLETED
-
Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis
NCT03694093 ·Status: COMPLETED
-
Endothelial Hyperpolarization in Humans
NCT00166166 ·Status: TERMINATED ·Phase: PHASE2
-
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
NCT00613886 ·Status: TERMINATED ·Phase: NA